Apyx Medical Corp (APYX) stock
APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3018% above fair value
$2.49−0.06 (-2.54%)
Close on Nov 18, 2026Market cap $104.89MP/E –Yield –
Apyx Medical free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Apyx Medical's free cash flow for the twelve months ending Jun 30, 2026 was -$11.05M. For fiscal 2025 it was -$9.12M. The highest annual figure on record is $1.36M in fiscal 2011.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.12M | – |
| FY2024 | Dec 31, 2024 | -$18.77M | – |
| FY2023 | Dec 31, 2023 | -$5.78M | – |
| FY2022 | Dec 31, 2022 | -$21.29M | – |
| FY2021 | Dec 31, 2021 | -$11.17M | – |
| FY2020 | Dec 31, 2020 | -$16.65M | – |
| FY2019 | Dec 31, 2019 | -$19.78M | – |
| FY2018 | Dec 31, 2018 | -$21.24M | – |
| FY2017 | Dec 31, 2017 | -$4.33M | – |
| FY2016 | Dec 31, 2016 | -$3.12M | – |
| FY2015 | Dec 31, 2015 | -$6.21M | – |
| FY2014 | Dec 31, 2014 | -$1.05M | – |
| FY2013 | Dec 31, 2013 | -$3.12M | – |
| FY2012 | Dec 31, 2012 | -$588.00K | -143.4% |
| FY2011 | Dec 31, 2011 | $1.36M | – |
| FY2010 | Dec 31, 2010 | -$727.00K | – |
| FY2009 | Dec 31, 2009 | -$2.56M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.56M | – |
| Q1 FY2026 | Mar 31, 2026 | -$632.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.81M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.06M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.50M | – |
| Q1 FY2025 | Mar 31, 2025 | -$757.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.18M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.59M | -230.4% |
| Q2 FY2024 | Jun 30, 2024 | -$4.62M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.38M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.31M | – |
| Q3 FY2023 | Sep 30, 2023 | $3.52M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.01M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.99M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.67M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.55M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.27M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.80M | – |
| Q4 FY2021 | Dec 31, 2021 | -$118.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.78M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.04M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.24M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.41M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.63M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.12M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.50M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.48M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.11M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.99M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.21M | – |
| Q4 FY2018 | Dec 31, 2018 | -$18.21M | -3484.0% |
| Q3 FY2018 | Sep 30, 2018 | -$1.03M | – |
| Q2 FY2018 | Jun 30, 2018 | -$766.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.25M | – |
| Q4 FY2017 | Dec 31, 2017 | $538.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$821.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.16M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.89M | – |
| Q4 FY2016 | Dec 31, 2016 | -$648.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$54.00K | – |
See a number that looks wrong?